{"id":22955,"date":"2024-06-13T08:09:57","date_gmt":"2024-06-13T12:09:57","guid":{"rendered":"https:\/\/medicarereport.org\/?p=22955"},"modified":"2024-06-13T08:09:58","modified_gmt":"2024-06-13T12:09:58","slug":"the-facts-about-the-35-insulin-copay-cap-in-medicare","status":"publish","type":"post","link":"https:\/\/medicarereport.org\/?p=22955","title":{"rendered":"The Facts About the $35 Insulin Copay Cap in Medicare"},"content":{"rendered":"\n

(By Juliette Cubanski and Tricia Neuman for The Kaiser Family Foundation Published: Jun 12, 2024)<\/p>\n\n\n\n

In a recent post on his social media platform, Donald Trump claimed credit for lowering insulin copayments to $35 for \u201cmillions of Americans,\u201d stating \u2013 inaccurately \u2013 that President Biden had \u201cnothing to do with it.\u201d This brief walks through the facts about actions taken under both the Trump and Biden Administrations related to capping insulin copayments for people with Medicare and explains the differences between their approaches. Continue reading here…<\/a><\/p>\n\n\n\n

\"\"<\/p>\n\n\n\n

Notice:<\/strong>\u00a0The link provided above connects readers to the full content of the posted article. The URL (internet address) for this link is valid on the posted date; medicarereport.org cannot guarantee the duration of the link\u2019s validity. Also, the opinions expressed in these postings are the viewpoints of the original source and are not explicitly endorsed by AMAC, Inc.; the AMAC Foundation, Inc.; or medicarereport.org.<\/p>\n","protected":false},"excerpt":{"rendered":"

(By Juliette Cubanski and Tricia Neuman for The Kaiser Family Foundation Published: Jun 12, 2024) In a recent post on<\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[35,21,20,6,15],"tags":[80,1361,1145,385,238,61,420,65],"class_list":["post-22955","post","type-post","status-publish","format-standard","hentry","category-elections-healthcare-issues","category-health-care-finance","category-health-care-redesign","category-medicare-general","category-part-dprescription-drugs","tag-cms","tag-copay-cap","tag-elections","tag-healthcare-costs","tag-healthcare-finance","tag-medicare","tag-medicare-insulin-cost-sharing","tag-medicare-part-d"],"_links":{"self":[{"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/posts\/22955","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/medicarereport.org\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=22955"}],"version-history":[{"count":1,"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/posts\/22955\/revisions"}],"predecessor-version":[{"id":22956,"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/posts\/22955\/revisions\/22956"}],"wp:attachment":[{"href":"https:\/\/medicarereport.org\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=22955"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/medicarereport.org\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=22955"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/medicarereport.org\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=22955"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}